
Breakthrough GLP-1 implant promises major weight-loss benefits for pets
Fox News
OKAVA Pharmaceuticals has announced testing of the world's first GLP-1 weight loss treatment for pets, successfully dosing the first cat in the MEOW-1 clinical study.
Angelica Stabile is a lifestyle reporter for Fox News Digital.
OKAVA Pharmaceuticals, the San Francisco-based manufacturer of the medication, said the landmark clinical study of the "first-in-class" device could have "profound" implications for diabetes, kidney disease, healthy aging and longevity in pets.
More Related News













